USFDA Audit Cleared - Bioanalytical Facility successfully closed an unannounced audit with zero observations | Global Recognition - CDMO Division participated as a Sponsor and Emerging Tech Partner at the European Pharma Outsourcing Summit (EPOS), Germany | Expanding Manufacturing Capabilities with enhanced capacity Dry Granulation (Roll Compactor), Low RH Manufacturing & High-Speed Capsule Filling

Special & Differentiated Products

R&D Solutions for Specialized Pharma Products

We are dedicated to providing cutting-edge special, differentiated and special pharma product development services. With a strong commitment to innovation and quality, we offer comprehensive solutions that cater to the evolving needs of the pharmaceutical industry. Our expertise in differentiated pharma product development services and modified pharma product development services ensures that we deliver high-quality pharmaceutical formulations that enhance therapeutic effectiveness and patient outcomes.

By leveraging advanced technologies, rigorous research methodologies and a customer-centric approach, we develop pharmaceutical solutions that address critical healthcare challenges and comply with global regulatory standards. Whether you require specialized formulations, novel drug delivery systems, or process optimization, VerGo Pharma Research is your trusted partner for pharmaceutical excellence.

 

Potent Product Development

A dedicated special products laboratory enabling Formulation and Analytical Development of Potent & Anti-cancer products up to OEB 3

 

Differentiated Pharmaceutical Product Development

At VerGo Pharma Research, we excel in differentiated pharmaceutical product development, setting new benchmarks in innovation and therapeutic effectiveness. Our approach includes:

  • Novel Drug Delivery Systems (NDDS): Enhancing bioavailability and controlled drug release through advanced technologies such as nano-formulations and lipid-based drug carriers.
  • Fixed-Dose Combinations (FDCs): Developing multi-active pharmaceutical ingredient (API) formulations for improved patient compliance and therapeutic synergy.
  • Extended-Release and Modified-Release Formulations: Optimizing drug absorption profiles, minimizing dosing frequency, and improving patient adherence.
  • Orally Disintegrating Tablets (ODTs), Effervescent Tablets and Sublingual Formulations: Creating patient-friendly dosage forms that offer rapid onset of action and ease of administration.
  • We also specialise in the development of Powder for Oral Suspension (PFOS) and have expertise with developing Bi-layered Tablets, MUPS (multi-unit particulate system) and Oral Liquids.
  • We have expertise with Patent Non-Infringement Strategies & Complex / Hybrid Formulations.

 

Partner with VerGo Pharma Research for Specialized Drug Development

VerGo Pharma Research is your trusted partner in special pharma product development services, with capabilities in developing potent formulations (up to OEB 3), along with differentiated and modified  pharma product development. Contact us today to accelerate your pharmaceutical innovation and  achieve market success.

Contact Us

Other Services